Country: Malta
Language: English
Source: Medicines Authority
LEVOFLOXACIN
Fresenius Kabi Italia S.r.l Via Camagre 41, 37063 Isola della Scala (Vr) , Italy
J01MA12
LEVOFLOXACIN 5 mg/ml
SOLUTION FOR INFUSION
LEVOFLOXACIN 5 mg/ml
POM
ANTIBACTERIALS FOR SYSTEMIC USE
Authorised
2009-10-21
1 of 11 PACKAGE LEAFLET: INFORMATION FOR THE USER Levofloxacin 5mg/ml solution for infusion. Levofloxacin Read all of this leaflet carefully before you are given this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, nurse or pharmacist. If you get any side effects, talk to your doctor nurse or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Levofloxacin is and what it is used for 2. What you need to know before you are given Levofloxacin 3. How to use Levofloxacin 4. Possible side effects 5. How to store Levofloxacin 6. Contents of the pack and other information 1. What Levofloxacin is and what it is used for The name of your medicine is Levofloxacine. Levofloxacin contains a medicine called levofloxacin. This belongs to a group of medicines called antibiotics. Levofloxacin is a ’quinolone’ antibiotic. It works by killing the bacteria that cause infections in your body. Levofloxacin can be used to treat infections of the: Lungs, in people with pneumonia Urinary tract, including your kidneys or bladder Prostate gland, where you have a long lasting infection Skin and underneath the skin, including muscles. This is sometimes called ‘soft tissue’ In some special situations, Levofloxacin may be used to lessen the chances of getting a pulmonary disease named anthrax or worsening of the disease after you are exposed to the bacteria causing anthrax. 2. What you need to know before you are given Levofloxacin Do not have this medicine and tell your doctor if: You are allergic to levofloxacin, any other quinolone antibiotic such as moxifloxacin, ciprofloxacin or ofloxacin or any of the other ingredients of this medicine (listed in section 6) Signs of an allergic reactivon include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue You have ever had epi Read the complete document
MT Levofloxacin SmPC Page 1 of 21 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Levofloxacin 5mg/ml solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 50 ml filled in 100 ml bottle/bags: Each ml of solution for infusion contains 5 mg levofloxacin (as levofloxacin hemihydrate). 50 ml of solution for infusion contains 250 mg of levofloxacin as active substance. 100 ml filled in 100 ml bottle/bags: Each ml of solution for infusion contains 5 mg levofloxacin (as levofloxacin hemihydrate). 100 ml of solution for infusion contains 500 mg of levofloxacin as active substance. Excipient(s) with known effect : The medicinal product contains 3.5 mg of sodium per ml. For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for infusion. Yellow to greenish yellow solution. 4. CLINICAL PARTICULARS 4.1. Therapeutic indications Levofloxacin solution for infusion is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1): Acute pyelonephritis and complicated urinary tract infections (see section 4.4) Chronic bacterial prostatitis Inhalation Anthrax: postexposure prophylaxis and curative treatment (see section 4.4). In the below-mentioned infections Levofloxacin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. Community-acquired pneumonia MT Levofloxacin SmPC Page 2 of 21 Complicated skin and soft tissue infections. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 Posology and method of administration Levofloxacin solution for infusion is administered by slow intravenous infusion once or twice daily. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen. Treatment with Levofloxacin after initial use of the intravenous preparation may be completed with an appropriate oral presentation as cons Read the complete document